Prenatal exclusion of Ehlers-Danlos syndrome type VI by mutational analysis

Proceedings of the Association of American Physicians

Volumn 111, Issue 1, 1999, Pages 57-62

  Yeowell, H N ^a   Walker, L C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autosomal recessive disorder; Chorionic villus cells; Collagen hydroxylation; Lysyl hydroxylase deficiency

Indexed keywords

CONFERENCE PAPER; EHLERS DANLOS SYNDROME; GENE ISOLATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; PRENATAL DIAGNOSIS;

EID: 0032910428     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1381.1999.09112.x     Document Type: Conference Paper

References (25)

1. Pinnell S.R. and Murad S. Disorders of collagen. In: Stanbury J.B., Wyngaarden J.B., Fredrickson J.L., et al. (eds). The Metabolic Basis of Inherited Disease. New York: McGraw‐Hill, 1983. Pp. 1425–1449.
2. 2 Myllyla R., Pajunen L., Kivirikko K.I. Polyclonal and monoclonal antibodies to human lysyl hydroxylase and studies on the molecular heterogeneity of the enzyme. Biochem. J. 253: 489 496, 1988.
3. 3 Steinmann B., Royce P.M., and Superti‐Furga A. The Ehlers‐Danlos syndrome. In: Royce P.M. and Steinmann B. (eds). Connective Tissue and its Heritable Disorders. New York: Wiley‐Liss, 1993. Pp. 351–407.
4. 4 Wenstrup R.J., Murad S., Pinnell S.R. Ehlers‐Danlos syndrome type VI: Clinical manifestations of collagen lysyl hydroxylase deficiency. J. Pediatr. 115: 405 409, 1989.
5. 5 Pinnell S.R., Krane S.M., Kenzora J.E., Glimcher M.J. A heritable disorder of connective tissue. Hydroxylysine‐deficient collagen disease. N. Engl. J. Med. 286: 1013 1020, 1972.
6. 6 Murad S. & Pinnell S.R. Suppression of fibroblast proliferation and lysyl hydroxylase activity by minoxidil. J. Biol. Chem. 262: 11973 11978, 1987.
7. 7 Hyland J., Ala‐Kokko L., Royce P., et al. A homozygous stop codon in the lysyl hydroxylase gene in two siblings with Ehlers‐Danlos syndrome type VI. Nat. Genet. 2: 228 231, 1992.
8. 8 Hautala T., Heikkinen J., Kivirikko K.I., Myllyla R. A large duplication in the gene for lysyl hydroxylase accounts for the type VI variant of Ehlers‐Danlos syndrome in two siblings. Genomics 15: 399 404, 1993.
9. 9 Pousi B., Hautala T., Heikkinen J., et al. Alu‐Alu recombination results in a duplication of seven exons in the lysyl hydroxylase gene in a patient with the type VI variant of Ehlers‐Danlos syndrome. Am. J. Hum. Genet. 55: 899 906, 1994.
10. 10 Heikkinen J., Toppinen T., Yeowell H.N., et al. Duplication of seven exons in the lysyl hydroxylase gene is associated with longer forms of a repetitive sequence within the gene and is a common cause for the type VI variant of Ehlers‐Danlos syndrome. Am. J. Hum. Genet. 60: 48 56, 1997.
11. 11 Ha V.T., Marshall M.K., Elsas L.J., et al. A patient with Ehlers‐Danlos syndrome type VI is a compound heterozygote for mutations in the lysyl hydroxylase gene. J. Clin. Invest. 93: 1716 1721, 1994.
12. 12 Yeowell H.N. & Walker L.C. Ehlers‐Danlos syndrome type VI results from a nonsense mutation and a splice site mediated exon‐skipping mutation in the lysyl hydroxylase gene. Proc. Assoc. Am. Phys. 109: 1 14, 1997.
13. 13 Murad S., Sivarajah A., Pinnell S.R. A comparison of lysyl hydroxylation in various types of collagen from type VI Ehlers‐Danlos syndrome fibroblasts. Coll. Rel. Res. 3: 511 515, 1983.
14. 14 Murad S., Sivarajah A., Pinnell S.R. Serum stimulation of lysyl hydroxylase activity in cultured human skin fibroblasts. Connect. Tissue Res. 13: 181 186, 1985.
15. 15 Murad S., Sivarajah A., Pinnell S.R. Prolyl and lysyl hydroxylase activities of human skin fibroblasts: Effect of donor age and ascorbate. J. Invest. Dermatol. 75: 404 –407, 1980.
16. 16 Chomczynski P. & Sacchi N. Single step method for RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform extraction. Anal. Biochem. 162: 156 159, 1987.
17. 17 Yeowell H.N., Murad S., Pinnell S.R. Hydralazine differentially increases mRNAs for the α and β subunits of prolyl 4‐hydroxylase whereas it decreases pro α1(I) collagen mRNAs in human skin fibroblasts. Arch. Biochem. Biophys. 289: 399 404, 1991.
18. 18 Yeowell H.N., Ha V.T., Clark W.L., et al. Sequence analysis of a cDNA for lysyl hydroxylase isolated from human skin fibroblasts from a normal donor: Differences from human placental lysyl hydroxylase cDNA. J. Invest. Dermatol. 102: 382 384, 1994.
19. 19 Yeowell H.N., Ha V., Walker L.C., et al. Characterization of a partial cDNA for lysyl hydroxylase from human skin fibroblasts; lysyl hydroxylase mRNAs are regulated differently by minoxidil derivatives and hydralazine. J. Invest. Dermatol. 99: 864 –869, 1992.
20. 20 Barbu V. & Dautry F. Northern blot normalization with a 28S rRNA oligonucleotide probe. Nucleic Acids Res. 262: 7115, 1989.
21. 21 Krol B.J., Murad S., Walker L.C., et al. The expression of a functional, secreted human lysyl hydroxylase in a baculovirus system. J. Invest. Dermatol. 106: 11 16, 1996.
22. 22 Maniatis T., Fritsch E.F., and Sambrook J. Molecular cloning, a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1982.
23. 23 Dembure P.P., Priest J.H., Snoddy S.C., Elsas L.J. Geneotyping and prenatal assessment of collagen lysyl hydroxylase deficiency in a family with Ehlers‐Danlos syndrome, type VI. Am. J. Hum. Genet. 36: 783 790, 1984.
24. 24 Maquat L.E. When cells stop making sense: Effects of nonsense codons on RNA metabolism in vertebrate cells. RNA 1: 453 465, 1995.
25. 25 Cui Y., Hagan K.W., Zhang S., Peltz S.W. Identification and characterization of genes that are required for the accelerated degradation of mRNAs containing a premature translational termination codon. Genes Dev. 9: 423 436, 1995.